Cysteine Peptidase Cathepsin X as a Therapeutic Target for Simultaneous TLR3/4-mediated Microglia Activation

Anja Pišlar1, Biljana Božić Nedeljković2, Mina Perić2

  • 1Department of Pharmaceutical Biology, Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, 1000, Ljubljana, Slovenia. anja.pislar@ffa.uni-lj.si.

Molecular Neurobiology
|January 23, 2022
PubMed

Insights

Simultaneous Toll-like receptor 3 and 4 activation in microglia boosts inflammation and neurodegeneration. Cathepsin X inhibition reduces these effects, highlighting its therapeutic potential for inflammatory neurodegenerative diseases.

Area of Science:

  • Neuroimmunology
  • Cellular and Molecular Neuroscience

Background:

  • Microglia, the central nervous system's immune cells, are activated by Toll-like receptors (TLRs).
  • Dysregulated microglia-mediated inflammation is implicated in neurodegenerative disorders.
  • The cysteine peptidase cathepsin X is a known factor in inflammation-driven neurodegeneration.

Purpose of the Study:

  • To investigate the synergistic effects of simultaneous TLR3 and TLR4 activation on microglia.
  • To determine how this co-activation influences cathepsin X expression and activity.
  • To explore cathepsin X as a potential therapeutic target in neuroinflammation.

Main Methods:

  • Murine microglia (BV2 cells and primary cultures) were stimulated with TLR3 ligand poly(I:C) and TLR4 ligand LPS, individually and together.
  • Analyzed inflammatory factor production, cathepsin X activity and localization.
  • Utilized cathepsin X inhibitor (AMS36) and PI3K inhibitor (LY294002) to assess signaling pathways and therapeutic potential.

Main Results:

  • TLR3 and TLR4 co-activation led to amplified inflammatory responses compared to single TLR activation.
  • Co-activation altered cathepsin X activity and localization, increasing extracellular levels.
  • Inhibiting cathepsin X or the PI3K pathway significantly reduced inflammatory cytokine production, apoptosis, and microglia activation.

Conclusions:

  • Microglial cathepsin X activity is enhanced by combined TLR3/TLR4 stimulation, contributing to neuroinflammation.
  • Cathepsin X plays a crucial role in amplifying microglia activation and subsequent neurodegeneration.
  • Targeting cathepsin X offers a promising therapeutic strategy for neurodegenerative diseases driven by inflammation.

Related Concept Videos